Envoy Medical Q1 2024 GAAP EPS $(0.32), Sales $59.00K Miss $100.00K Estimate
Portfolio Pulse from Benzinga Newsdesk
Envoy Medical (NASDAQ:COCH) reported a Q1 2024 GAAP EPS of $(0.32) and sales of $59.00K, missing the analyst consensus estimate of $100.00K by 41%.
May 15, 2024 | 8:42 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Envoy Medical reported a Q1 2024 GAAP EPS of $(0.32) and sales of $59.00K, missing the analyst consensus estimate of $100.00K by 41%.
The significant miss on both EPS and sales compared to analyst estimates is likely to negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100